ResMed [ASX:RMD] Reports Revenue Growth of 16%

Medical devices and cloud applications developer ResMed has reached $1.4 billion in revenue, an increase of 16%, growing profits by 13% and non-GAAP operating profits by 14%.

Related Keywords

Australia ,Australian , ,Resmed Inc ,Rd Research ,Reports Revenue Growth ,Australian Financial ,